tiprankstipranks
Affimed Therapeutics’ Optimistic Clinical Outlook
PremiumCompany AnnouncementsAffimed Therapeutics’ Optimistic Clinical Outlook
27d ago
Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024
PremiumPress Releases
Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024
1M ago
AFMD Earnings this Week: How Will it Perform?
PremiumPre-Earnings
AFMD Earnings this Week: How Will it Perform?
1M ago
Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer
PremiumPress ReleasesAffimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer
4M ago
Affimed announces strategic restructuring, reducing headcount by 50%
PremiumThe Fly
Affimed announces strategic restructuring, reducing headcount by 50%
4M ago
Affimed CEO Adi Hoess to step down
PremiumThe Fly
Affimed CEO Adi Hoess to step down
4M ago
Affimed to hold a pharmaceutical update conference call
PremiumThe FlyAffimed to hold a pharmaceutical update conference call
4M ago
Affimed discontinues enrollment in AFM24-102 into gastric cancer, basket cohorts
PremiumThe Fly
Affimed discontinues enrollment in AFM24-102 into gastric cancer, basket cohorts
5M ago
Affimed presents data from AFM24-102 Phase 1/2a combination study
PremiumThe Fly
Affimed presents data from AFM24-102 Phase 1/2a combination study
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100